In tissues and fluids - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

In tissues and fluids

Description:

a. do not bind and/or activate complement - polysaccharide capsules ... Varicella zoster (chicken pox) re-emerges later in life as shingles after being ... – PowerPoint PPT presentation

Number of Views:56
Avg rating:3.0/5.0
Slides: 12
Provided by: paula92
Category:

less

Transcript and Presenter's Notes

Title: In tissues and fluids


1
In tissues and fluids 1. Complement virulenc
e mechanisms for evasion a. do not bind
and/or activate complement - polysaccharide
capsules b. cause inhibition of activation
and amplification cascade - bind factor H (M
protein of streptococci) c. degrade
complement - secrete proteases d.
complement receptor homologs (viruses) e.
secrete complement homologs C4b homolog
(vaccinia virus) inhibits C cascade
2
2. Phagocytes - beyond mucosal surface i.
EXTRACELLULAR vs. INTRACELLULAR pathogens ii.
extracellular antiphagocytic functions
?inhibit recruitment - inhibit complement,
cytokines ?kill the phagocytes - toxins
?prevent phagocytosis - prevent opsonization,
prevent binding (carbohydrate capsules) iii.
intracellular pathogen functions ?inhibit
phagosome-lysosome fusion ?escape
phago(lyso)some into cytoplasm ?inhibit
oxidative burst ?resist antimicrobial functions
3
Cytokines
  • IL-1
  • B13R protein of vaccinia virus inhibits ICE (IL-1
    converting enzyme), preventing formation of
    IL-1ß, down regulating inflammation and
    inhibiting apoptosis
  • B15R protein of vaccinia virus - IL-1 receptor
    homologous
  • TNF-a
  • pox viruses secrete TNF receptor homologs that
    can bind TNF-a
  • Interferons
  • IFN-? receptor homologs secreted by myxoma virus
    and vaccinia virus
  • IFN-a/ß receptor homologs secreted by vaccinia
    virus
  • Vaccinia virus E3L and K3L proteins inhibit
    different parts of IFN-mediated intracellular
    antiviral functions

4
Figure 11-5
5
Immune Host c. Antibodies i. antigenic
mimicry - surface components look like host
?polysialic acid capsule of Neisseria
meningitidis ii. antigenic cloaking - bind host
proteins to bacterial surface ?protein A of
Staphylococcus aureus iii. antigenic variation
- change antigenic composition ?pili of
Neisseria gonorrhoea ?Hemagglutinin of
Influenza virus (shift and drift) iv. antigenic
variety -numerous serological types among strains
in the world (each strain is antigenically
stable) ?M protein of Streptococcus
pyogenes v. degrade antibodies ?IgAse of
Haemophilus influenzae
6
Figure 11-3 part 2 of 2
7
Figure 11-1
8
  • d. Cell-mediated immunity
  • ?alter host response from cell-mediated (Th1) to
    antibody (Th2) response - Mycobacterium leprae
  • M. leprae - intracellular pathogen of macrophages
    - replicates within macrophages
  • Antibodies (Th2-regulated) are ineffective and
    probably detrimental
  • Cell-mediated immunity (Th1 regulated) is
    protective
  • M. leprae causes some people to produce primarily
    an antibody response by affecting cytokine gene
    expression (lepromatous leprosy)
  • People who make CMI responses have mild disease
    (tuberculous leprosy)

9
Figure 11-6
10
Humoral and Cell-mediated
  • Latency of viruses
  • hide out until the coast is clear (many Herpes
    viruses)
  • Varicella zoster (chicken pox) re-emerges later
    in life as shingles after being latent in nerve
    ganglia

11
Figure 11-4
Write a Comment
User Comments (0)
About PowerShow.com